Navigation Links
Research center to develop next generation of advanced chemical products

A new 7 million centre at the University of Leeds will lead UK research in manufacturing advanced chemical products.

The Centre for Doctoral Training (CDT) in Complex Particulate Products and Processes will fund 50 new research students in a field that has been targeted by the Government as a key growth area for the UK economy.

"Advanced formulated chemical products are worth more than 200 billion a year to the UK economy and are used in a wide range of sectors, from advanced drugs and protecting crops through to the toiletries we use," said Professor Simon Biggs, of the University of Leeds' Faculty of Engineering, who led the bid. "Our centre will be working across the whole supply chain, whether that's discovering new materials, getting these things on the manufacturing line or delivering them to consumers."

The new facility is one of 22 new CDTs announced by the Chancellor of the Exchequer, the Rt. Hon George Osborne MP, in Manchester today (March 28, 2014). Government money, allocated by the Engineering and Physical Science Research Council (EPSRC), will provide more than half of the centre's funding, with the remainder coming from the University and industrial partners.

Companies backing the CDT include the multinational consumer goods company Procter & Gamble (P&G), agrochemical developer Syngenta, petroleum additives manufacturer Infineum and major drug companies including GlaxoSmithKline, Pfizer and AstraZeneca.

Professor Biggs said: "This is not just about researchers sitting in their labs formulating clever materials. One of the problems in research is that a molecule might be ideal in theory but it may be impossible to manufacture it at scale and at a cost that can be supported by the market.

"We are going to be training researchers who can see the whole picture. An engineer looking at manufacturing problems will need to understand the limitations and restrictions of the chemist. The chemist will need to engage with the production line and the market. They will work in cross-disciplinary teams. The focus is on developing people who can go out there and continue the UK's leadership in this field."

One key area of work is "micro encapsulation," which allows active ingredients in products such as drugs, agrochemicals, foods, cleaning products and toiletries to be better targeted.

"Think about chemotherapy. It kills cancer cells but it also kills off a lot of good tissue. If we can encapsulate those active ingredients on the micro-scale, so that they are only released on the cancer cells, we could give you a lot less drug and be better at targeting the cancer. We might also be reducing the cost of the drug because we need a lot less active ingredient," Professor Biggs said.

Other applications include micro capsules that slowly leak active ingredients in pesticides, protecting a plant over an extended period, or micro-packages that preserve active ingredients in cleaning products so that they remain effective after months in the supply chain.

"A Malteser is an 'encapsulated' piece of honeycomb. Our honeycomb might be a drug, an agrochemical, something in your shampoo or an additive to your engine lubricant," Professor Biggs said.

The CDT will involve academics from the University's School of Process, Environmental and Materials Engineering, School of Mechanical Engineering, School of Chemistry, School of Design, School of Food Science and Nutrition and Leeds University Business School.

Research students are expected to be recruited from backgrounds including chemistry, physics, material engineering, product engineering and product design.

The first cohort of 10 PhD students will start work in October.

Contact: Chris Bunting
University of Leeds

Related biology news :

1. Research from CHORI scientists demonstrates first genome methylation in fruit fly
2. GW researcher invents mini heart to help return venous blood
3. Clemson researcher touts surgical safety checklist to save lives
4. Researchers at IRB discover a key regulator of colon cancer
5. Researchers reveal the dynamics behind Arctic ecosystems
6. IRCM researchers uncover a new function for an important player in the immune response
7. HFSP research funding for the Helmholtz Zentrum München
8. UGA researchers explore function of cancer-causing gene
9. CASIS-sponsored research heads to space station aboard SpaceX-3
10. Distinguished researcher to speak at NJIT on preventing bone loss
11. Researchers present comprehensive roadmap of blood cells
Post Your Comments:
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... BOSTON , Oct. 29, 2015  Connected health ... phenomena driving the explosion of technology-enabled health and wellness, ... his new book, The Internet of Healthy ... apps, sensors or smartphones even existed, Dr. Kvedar, vice ... model of health care delivery, moving care from the ...
Breaking Biology News(10 mins):
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
(Date:11/25/2015)... Studies reveal the differences in species of bacteria ... for more effective treatment for one of the most commonly ... --> --> Gum disease is one ... relatively little was understood about the bacteria associated with it ... researchers from the WALTHAM Centre for Pet Nutrition together with ...
(Date:11/25/2015)... 2015 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... fireside chat discussion at the Piper Jaffray 27th Annual ... The discussion is scheduled for Wednesday, December 2, at ... A replay will be available for 14 days after ... Julie NormartVP, Corporate Communications and Business Development , BrewLife(858) ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
Breaking Biology Technology: